FP7Индивидуална стипендия2015–2017

HEART BETAS · The Role of Beta-Adrenergic Signaling in Cardiac Progenitor Cell Activation after Myocardial Infarction

7РП — „Хора“ (Действия „Мария Кюри“)

Период
2015-04-14 → 2017-04-13
Финансиране от ЕС
202 406 €
Участници
1
Схема
MC-IIF

Линиите свързват координатора с партньорите.

Накратко на български

Сърдечните прогениторни клетки и тяхната реакция към бета-адренергични рецептори се анализират чрез опити с мишки след инфаркт. Това помага да се разбере как тези клетки влияят върху възстановяването на сърцето и промяната на тъканите му.

Този кратък обзор е генериран от изкуствен интелект

Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.

Резултати накратко

The Role of Beta-Adrenergic Signaling in Cardiac Progenitor Cell Activation after Myocardial Infarction

The objective of Heart Betas was to understand if resident cardiac progenitor cells (CPC) could be affected by β- adrenergic receptor signaling therapies that are critical in the current management of cardiovascular diseases. In particular, the general hypothesis proposed was that β2-adrenergic receptor signaling after a myocardial infarction (MI) favors the activation of endogenous CPC and thereby aids in improved cardiac remodeling. The first objective was to use a mouse model of MI to evaluate the response of CPC after treatment with β-adrenergic agonists/antagonists. The second objective was to investigate the hypothesis that β2-adrenergic signaling mediates CPC proliferation and migration through the regulation of intracellular calcium. CPC β1 and β2 ARs expression was evaluated in vivo and in vitro. A significant increase in the percentage of CPCs expressing β1 and β2 ARs was measured 7 days post-MI. Accordingly, 24 hours of low serum and hypoxia in vitro significantly increased CPC β2 AR expression. Cell viability and differentiation assays validated a functional role of CPC β2 AR. The effect of pharmacological activation of β2 ARs was studied using fenoterol, administered in the drinking water either 1 week prior to MI or sham surgery or at the time of surgery. Immunofluorescence analysis of the heart tissue for proliferation, cardiomyocytes surface area, and vessel density showed significant changes based on surgery but no benefit due to fenoterol treatment. MI induced a significant increase in the percentage of CPC at 7 days, while pre-treatment with fenoterol prolonged this response resulting in a significant elevated number of CPC up to 21 days post-MI. Although cardiac function was not ameliorated when evaluated by echocardiography, infarct size was significantly reduced in mice pre-treated with fenoterol. The final results of the project indicate that β2 adrenergic receptors can play a role in CPC proliferation and differentiation with their expression level adapting to stressful environments. In particular, in vivo stimulation of β2 adrenergic receptors significantly increased the local CPC pool in the myocardium and was associated with a decrease in infarct size, supporting the original hypothesis of the project. Myocardial infarction and ischemic heart disease continues to remain a significant societal and clinical problem. The results obtained in this fellowship offer insight on how to manipulate the endogenous healing process, potentially through better clinical pharmacological therapy and management, with the long-term aim of improving outcomes post-MI and hopefully lessening the burden in treating this disease.

Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз

Цел на проекта

Cardiovascular diseases are a leading cause of mortality in the industrialized world with myocardial infarction (MI) being one of the common pathological events. Cardiac progenitor cells (CPC) are a progenitor cell population within the myocardium and are activated after MI to proliferate, migrate to the infarct site, and participate in cardiac regeneration. CPC are a current therapeutic target to diminish cardiac injury after a MI. After a MI, the beta-adrenergic system gets activated due to excessive concentrations of catecholamines accumulating in the myocardium. Interestingly, beta-2 adrenergic signaling has been suggested to promote CPC proliferation. It is currently unknown whether resident CPC could be affected by β-adrenergic signaling therapies. We therefore propose the general hypothesis that beta2-adrenergic receptor signaling after a MI favors the activation of endogenous CPC. We will use a mouse model of MI to evaluate the activation of CPC after treatment with beta-adrenergic agonists/antagonists. CPC will be analyzed by flow cytometry and immunohistochemistry. Cardiac outcomes (infarct size and arrhythmic events) will be correlated to the activation of the CPC. We will further investigate the hypothesis that beta2-adrenergic signaling mediates CPC activation through the regulation of intracellular calcium. We will treat murine and human CPC with beta-adrenergic agonists/antagonists and examine changes in intracellular calcium flux. We will correlate the effect of beta-adrenergic signaling on CPC proliferation and migration in vitro to calcium handling. Validation of our hypothesis would begin to dissect the natural molecular signals that are an integral part of myocardial healing.

Оригинален текст от CORDIS (на английски).

Участници

  • INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE · ParisКоординаторФранция

Връзки

Данни: CORDIS, © Европейски съюз